Fatigue is a common symptom experienced by cancer survivors. It is important for the clinician to question the patient about the presence of this symptom because patients are often hesitant to mention it. In addition, cancer-related fatigue (CRF) commonly clusters with other symptoms, such as sleep disturbance, pain, depression, and anxiety. Patients with moderate to severe CRF should undergo a comprehensive evaluation that includes a history, physical examination, laboratory evaluation, and an assessment of their fatigue and possible associated symptoms. Nonpharmacologic interventions for the treatment of CRF include psychosocial interventions, activity enhancement, dietary management, and sleep management; pharmacologic interventions include agents such as stimulants. Further research is needed to elucidate the actual pathophysiology of CRF and better tailor treatment strategies.
KeywordsObstructive Sleep Apnea Cancer Survivor National Comprehensive Cancer Network Psychosocial Intervention Activity Enhancement
- Gabrilove JL, Perez E, Tomita DK, Rossi G, Cleeland CS. Assessing symptom burden using the MD Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 micrograms every 2 weeks. Cancer 2007;110(7):1629–1640.PubMedCrossRefGoogle Scholar
- Jean-Pierre P, Morrow GR, Roscoe JA, et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 2010;116(14):3513–3520.PubMedCrossRefPubMedCentralGoogle Scholar
- Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 2000;14(11A):151–161.Google Scholar
- Morrow GR, Jean-Pierre P, Roscoe JA, et al. A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: a URCC CCOP study (abstract). J Clin Oncol 2008;504s.Google Scholar